Aktie A2QQZ6 LONGBOARD PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Longboard Pharmaceuticals, Inc.

Aktien

A2QQZ6

US54300N1037

LBPH

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 26.04.2024 		% 5 Tage % 1. Jan.
19,72 USD +2,44 % Intraday Chart für Longboard Pharmaceuticals, Inc. +13,07 % +227,03 %
12.03. Longboard Pharmaceuticals, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
16.01. LONGBOARD PHARMACEUTICALS, INC. : Cantor Fitzgerald bekräftigt seine Kaufempfehlung ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding
Longboard Pharmaceuticals, Inc.(NasdaqGM:LBPH) added to S&P Pharmaceuticals Select Industry Index
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES
Longboard Pharmaceuticals Closes $242 Million Public Offering
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Longboard Pharmaceuticals Prices $210 Million Stock Offering
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
LONGBOARD PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE DATA FROM THE PACIFIC STUDY, A PHASE 1B/2A CLINICAL TRIAL, FOR BEXICASERIN IN PARTICIPANTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
Longboard Pharmaceuticals Launching Share Offering
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
Sector Update: Health Care Stocks Gain Late Afternoon
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QQZ6 Aktie
  4. Nachrichten Longboard Pharmaceuticals, Inc.
  5. Andere Sprachen